Sunday, May 5, 2024
Part Four Of Five: Pfizer's Q1 2024 Lobby Spending: Pretty High, In An Election Year...
›
We will head out shortly, on mountain bikes by the lake. . . to find out teasured tace trucks -- and dine al fresco on some perfect soft po...
1 comment:
Saturday, May 4, 2024
And, Here Is What Amazon Spent $4.35 Million Lobbying On, In Q1 2024...
›
To be certain, here -- this is not a complete listing. Far from it. I've decided to focus on the areas we cover here -- less about soft...
NASA Highlights A Paper On "Synthetic Life" -- That Might Be Engineered In Zero Gravity...
›
There are profound ethical questions here. Ones that reasonable people will no doubt disagree about. And to their credit, NASA scientists ...
Now, Abbott Labs, A Second Tier Pharma... Has Spent About What Lilly Did, In Q1 2024, On Lobbyists.
›
In other years, I had compared Abbott to Baxter, but as Baxter retools and likely spins off or sells the Kidney Care business, it has dropp...
Actually, This Past Quarter, Lilly Spent Even Less Than Merck -- Lobbying (Despite The Insulin Pricing Battle In Congress)...
›
Part Two, of the likely five part series on Q1 2024 Lobby-Spend trends, now appears for " Fourth Be With You " day. . . . Lilly ...
Friday, May 3, 2024
ESA Offers Some Gorgeous Solar Coronal Mass Ejection Video Footage -- And... Run For The Roses Day, Tomorrow...
›
Without any more intro then -- from our friends on the Continent: So, do take a look; it is only about 45 seconds long. . . . Onward, loo...
Genuine Question: Should We Infer An Anti-Competitive Motive, When A Needed Vaccine For ~80,000 Oncology Patients Remains Subject To Stock-Outs, For... A Decade? [Cough. Merck.]
›
We've followed this for well-over eight long years -- the odd little vaccine that is part of certain bladder cancer treatments, as a fi...
Tangent: Hopefully My Last Mention -- Of Martin Shkreli's "Troubles" -- In Relaunching Some *.inu Token, Here In 2024...
›
I elsewhere mentioned that Mr. Shkreli was apparently calling out what he regarded as other scammers , about token air-drops related to som...
3 comments:
Thursday, May 2, 2024
The Merck Lanham Act Name Spat Case Has Been Reassigned To A New Jersey Federal Judge: Hon. Jamel K. Semper
›
And so, the trial date could possibly be moved forward -- into late 2024, given the less-crowded calendar of USDC Judge Semper. He was onl...
The Curious Story Of... ECMO, And Access Questions In ICUs, Inside The US.
›
This is not -- in any sense -- any new therapeutic option, but in fact one that dates ( brace yourself ) to. . . 1932. It historically has ...
More To Come, Shortly -- On The Others, But Merck Has Been Very Judicious In Its Q1 2024 Lobby Spending...
›
And that is true, when compared to peers -- as well as to the prior year's Q1 spend. Q1 2023 spend figures are in half tone grays at ri...
Some Good News -- But Again, Largely Immaterial.
›
[This is just a short Thursday filler-post, with the immortal beloved Jedis to arrive shortly. . . then the Revenge of the Sixth. Grin -- w...
Wednesday, May 1, 2024
May 1 UPDATE: Amazon / NLRB Wrangling Update, Related To AMZN / JFK-8 Lawless Union Busting Tactics...
›
Here is our monthly check in, to highlight the NLRB staff counsel's very cogent brief in defending a post decision ruling , out of Phoe...
[Huge Revenue Miss!] Tangent: Bitcoin Drops Below $57,000 Overnight, In Asia On Macro Fears — Riot’s Results A Drag, As Well…
›
Perfect storm a-comin’, for Riot when NASDAQ opens. Fear abounds in crypto as US fed decision day arrives. Will update at 8:30 am Easter...
Tuesday, April 30, 2024
Tangent: The Supremes Tell Musk... "Tell Your Story Walkin', Bub..."
›
Welp. This has turned out just as we said it would. When you lead a public company, and take the public's funding -- you are subject to...
Monday, April 29, 2024
Of "Vampire Facials"... That End Up Being... Debilitating, Life Long Medical Problems.
›
It has been a minute since I put up an "unlicensed, unapproved" medicines post. But this one. . . is so egregious, it rivals J...
Anon. Points Us To The Layoff News At BMS -- As Its Keytruda® (Pembrolizumab) Competitor, Called Opdivo®, Saw Declining Sales Last Year, And In Q1 2024...
›
From about mid-2014 to late-2017, the immuno oncology " horse race " was on, between Merck's bio-engineered PD-1 inhibitor (b...
Sunday, April 28, 2024
It Seems Dark Energy -- Universe-Wide -- Is... "Thawing?" That Is, It Seems To Be... Waning.
›
As ever, first -- the caveats: the data is strong, but the universe is very vary large. Very large. So over billions of light years, small ...
2 comments:
Saturday, April 27, 2024
As In June Of 2021, Hubble's Third Gyroscope Is Rendering Inconsistent Readings -- Hubble May Go To A One Gyro- Slew Configuration...
›
This 'scope has been in service since 1990 -- and last had six gyros installed in 2009, by the then space shuttle "capture / repai...
The River Buoy / Razor Wire Barriers Will Be Removed, But USDC Judge Ezra Ruled That The Treaty Is Not "Self-Executing".
›
This is a small update -- as Judge Ezra has also ruled that all of the federal government Rivers and Harbors Act claims, and the immigrati...
›
Home
View web version